Johnson & Johnson submitted an emergency use listing to WHO for its COVID-19 vaccine.
Johnson & Johnson (J&J) on Friday said that it had submitted an emergency use listing (EUL) to the World Health Organization (WHO) for its COVID-19 vaccine.
According to Johnson & Johnson, the process was a prerequisite to supply COVID-19 vaccines to the COVAX vaccine program co-led by the World Health Organization, which aimed to deliver COVID-19 vaccine doses to poor and middle-income countries.
The Emergency Use Listing (EUL), according to the World Health Organization, was a “risk-based procedure” for assessing and listing unlicensed vaccines, therapeutics, and in vitro diagnostics with the ultimate aim of “expediting the availability of these products to people affected by a public health emergency”.
Johnson & Johnson entered into an agreement last December 2020 in support of the COVAX program.
Moreover, Johnson & Johnson said that the company and Gavi — which also co-led the COVAX program — expected to enter into an advance purchase agreement that would provide up to 500 million single-dose COVID-19 vaccine doses to COVAX through 2022.
READ ALSO: AFP Gives Update On PSG Members Who Were Vaccinated Before FDA Approval
Meanwhile, the Department of Science and Technology (DOST) on Friday said that Janssen Pharmaceuticals — a subsidiary of Johnson & Johnson — had already started its COVID-19 vaccine clinical trials in the Philippines.
In a press briefing hosted by the Department of Health (DOH), DOST Undersecretary Dr. Rowena Cristina Guevara said that Janssen Pharmaceuticals had already started with their clinical trials in the Philippines, while site preparations were ongoing for the clinical trials of COVID-19 vaccine developers Sinovac and Clover.
However, Guevara refused to disclose other details of Janssen’s clinical trials — including the number of individuals who participated in the said trials — and said that information on independent human clinical trials can only be disclosed by the vaccine developers.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
